1. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2
    Zhen Yang et al, 2021, Cancer Biology & Therapy CrossRef
  2. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
    Jing Chen et al, 2019, Aging CrossRef
  3. DUXAP8: A Promising lncRNA with Carcinogenic Potential in Cancer
    Gang Zhou et al, 2022, Current Medicinal Chemistry CrossRef
  4. Pseudogene MSTO2P Interacts with miR-128-3p to Regulate Coptisine Sensitivity of Non-Small-Cell Lung Cancer (NSCLC) through TGF-β Signaling and VEGFC
    Minwei Gu et al, 2022, Journal of Oncology CrossRef
  5. Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
    Yi Liu et al, 2021, Bioscience Reports CrossRef
  6. m6A Modification-Mediated DUXAP8 Regulation of Malignant Phenotype and Chemotherapy Resistance of Hepatocellular Carcinoma Through miR-584-5p/MAPK1/ERK Pathway Axis
    Zefeng Liu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef

  7. Long Non-Coding RNA DUXAP8 Facilitates Cell Viability, Migration, and Glycolysis in Non-Small-Cell Lung Cancer via Regulating HK2 and LDHA by Inhibition of miR-409-3p


    Dianhe Yin et al, 2020, OncoTargets and Therapy CrossRef